Champions Oncology, Inc. (CSBR)
5.03
+0.26
(+5.45%)
USD |
NASDAQ |
Sep 16, 13:23
Champions Oncology Enterprise Value : 73.57M for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 73.57M |
| September 14, 2026 | 75.66M |
| September 11, 2026 | 78.16M |
| September 10, 2026 | 78.10M |
| September 09, 2026 | 76.91M |
| September 08, 2026 | 77.47M |
| September 04, 2026 | 79.83M |
| September 03, 2026 | 80.67M |
| September 02, 2026 | 78.86M |
| September 01, 2026 | 76.77M |
| August 31, 2026 | 76.70M |
| August 28, 2026 | 75.80M |
| August 27, 2026 | 77.05M |
| August 26, 2026 | 75.66M |
| August 25, 2026 | 76.49M |
| August 24, 2026 | 76.35M |
| August 21, 2026 | 76.22M |
| August 20, 2026 | 79.28M |
| August 19, 2026 | 75.94M |
| August 18, 2026 | 78.02M |
| August 17, 2026 | 77.19M |
| August 14, 2026 | 77.68M |
| August 13, 2026 | 77.89M |
| August 12, 2026 | 76.08M |
| August 11, 2026 | 76.63M |
| Date | Value |
|---|---|
| August 10, 2026 | 78.72M |
| August 07, 2026 | 79.42M |
| August 06, 2026 | 79.42M |
| August 05, 2026 | 80.95M |
| August 04, 2026 | 83.04M |
| August 03, 2026 | 87.35M |
| July 31, 2026 | 81.78M |
| July 30, 2026 | 72.90M |
| July 29, 2026 | 75.68M |
| July 28, 2026 | 76.65M |
| July 27, 2026 | 84.01M |
| July 24, 2026 | 84.98M |
| July 23, 2026 | 83.18M |
| July 22, 2026 | 84.98M |
| July 21, 2026 | 84.56M |
| July 20, 2026 | 84.56M |
| July 17, 2026 | 84.98M |
| July 16, 2026 | 80.95M |
| July 15, 2026 | 80.12M |
| July 14, 2026 | 78.45M |
| July 13, 2026 | 80.54M |
| July 10, 2026 | 80.68M |
| July 09, 2026 | 80.54M |
| July 08, 2026 | 84.09M |
| July 07, 2026 | 81.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medpace Holdings, Inc. | 16.92B |
| Avantor, Inc. | 13.84B |
| Personalis, Inc. | 1.538B |
| Adaptive Biotechnologies Corp. | 4.318B |
| 10X Genomics, Inc. | 9.218B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.426M |
| Revenue (Quarterly) | 15.23M |
| Total Expenses (Quarterly) | 15.66M |
| EPS Diluted (Quarterly) | -0.0306 |
| Gross Profit Margin (Quarterly) | 48.48% |
| Profit Margin (Quarterly) | -2.80% |
| Earnings Yield | -1.59% |
| Normalized Earnings Yield | -1.594 |